Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study
about
5-HT(2B) receptors play a key role in mediating the excitatory effects of 5-HT in human colon in vitroGenetic epidemiology of irritable bowel syndromeIrritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndromeGenetic polymorphism in pathogenesis of irritable bowel syndromeAn Endogenous Tachykinergic NK2/NK3 Receptor Cascade System Controlling the Release of Serotonin from Colonic MucosaMechanical stimulation activates Galphaq signaling pathways and 5-hydroxytryptamine release from human carcinoid BON cellsMethane and the gastrointestinal tract.Elevated pro-inflammatory and lipotoxic mucosal lipids characterise irritable bowel syndrome.Irritable bowel syndrome: the role of food in pathogenesis and management.Sildenafil normalizes bowel transit in preclinical models of constipationGender-related differences in irritable bowel syndrome: potential mechanisms of sex hormones.Identification of a functional TPH1 polymorphism associated with irritable bowel syndrome bowel habit subtypes.Immune activation and gut microbes in irritable bowel syndrome.Plasma 5-hydroxytryptamine concentration and its correlation with psychopathology in patients with irritable bowel syndrome.Rotavirus stimulates release of serotonin (5-HT) from human enterochromaffin cells and activates brain structures involved in nausea and vomitingEffect of electroacupuncture on visceral hyperalgesia, serotonin and fos expression in an animal model of irritable bowel syndrome.Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Methods to assess visceral hypersensitivity in irritable bowel syndrome.5-Hydroxytryptamine (5-HT) cellular sequestration during chronic exposure delays 5-HT3 receptor resensitization due to its subsequent release.Complementary and alternative medicine modalities for the treatment of irritable bowel syndrome: facts or myths?Acute tryptophan depletion affects brain-gut responses in irritable bowel syndrome patients and controls.Antibiotics for irritable bowel syndrome: rationale and current evidence.Associations of tryptophan hydroxylase gene polymorphisms with irritable bowel syndrome.Pharmacotherapy: non-serotonergic mechanisms.The relationship between perioperative nausea and vomiting and serum serotonin concentrations in patients undergoing cesarean section under epidural anesthesia.Increased defecation during stress or after 5-hydroxytryptophan: selective inhibition by the 5-HT(4) receptor antagonist, SB-207266.Elevated expression of c-fos in central nervous system correlates with visceral hypersensitivity in irritable bowel syndrome (IBS): a new target for IBS treatment.Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndromeAn exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndromeCharacteristics of 5-hydroxytryptamine receptors involved in contraction of feline ileal longitudinal smooth muscle.Of actors, bolting horses, and drops in oceans!Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndromeAssociation between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women.Schisandra chinensis reverses visceral hypersensitivity in a neonatal-maternal separated rat model.JCM-16021, a Chinese Herbal Formula, Attenuated Visceral Hyperalgesia in TNBS-Induced Postinflammatory Irritable Bowel Syndrome through Reducing Colonic EC Cell Hyperplasia and Serotonin Availability in RatsRotavirus and Serotonin Cross-Talk in DiarrhoeaAcute oral ethanol exposure triggers asthma in cockroach allergen-sensitized mice.FFA2 activation combined with ulcerogenic COX inhibition induces duodenal mucosal injury via the 5-HT pathway in rats.The rationale, efficacy and safety evidence for tegaserod in the treatment of irritable bowel syndrome.A role for endogenous peptide YY in tachykinin NK(2) receptor-triggered 5-HT release from guinea pig isolated colonic mucosaHistopathological alterations in irritable bowel syndrome.
P2860
Q24673230-2353FCB0-AED9-4461-910A-FD67D6BFA7F5Q26777392-DE9D9130-4BAE-4EDB-9310-AFBDB0348BE8Q26860280-9819F15E-742F-4E8D-B8FB-4F4F8BBC54B5Q27008164-361A5A48-7184-43D5-924B-0B3ECB7DAAAEQ28081884-156C22A7-DB30-4C22-9E3C-631859C3112CQ28360745-1E6B47B8-74C0-4B1C-8824-0464D4DBF563Q33443954-86559CF6-4D2F-4A1B-A767-D8AB5DEDE4E4Q33555354-EA393011-BD11-47A7-AD2F-2071D9D40C9CQ33582170-2BE99CB6-3B77-4C6D-94D2-1178F395E940Q33610799-8061E70A-1CCB-4CA4-AD2F-53E0D80F0F09Q33735218-8B2C3105-AC41-44CA-A457-566DC912D593Q33795126-0C964841-05B0-4165-A5C9-BB4608AEB4F5Q33855474-88B03675-79B1-4D6B-BB6D-9F11913805BBQ33855518-1A63B3ED-01E9-40A9-9598-57FF7197BE01Q33967946-7F4A01F2-FC84-4BFF-9AF3-A8FA6B19E42AQ34028451-07236965-4AF5-4872-AF87-3312263D9E32Q34273007-68ADAA19-772A-45CD-937B-395BA7EA11C8Q34509740-6BD90F06-7A53-442A-AC3C-51048183EBCBQ34551320-41EC2852-B370-4E3B-B081-A328813A822DQ34552619-67DABBB1-557B-47EC-B0CC-4129C6217C80Q34642080-26C1235B-5356-4075-BD12-F721B17E3905Q34673928-8B826F06-880C-4CEC-BAEB-74139231CF88Q34699864-A15F37AA-E7B5-43AA-A1BC-4F9C526BC708Q34792198-4DE44C20-13A7-4F49-981A-CC3CA4DF2852Q35042318-C7C1B3BD-0C15-4854-B9F4-E1AECC598A3BQ35120008-2B4DD95A-90C8-433E-801F-6EDCCC740A16Q35362266-6D523463-8170-442A-BB0B-E4E2DB1677F3Q35362585-606F5328-3E2E-42C2-AE78-96FFFE7D9FADQ35569347-27CD9589-93B6-4E80-B47D-84A012A289B6Q35595593-144EEABC-D4F8-4EDE-BBAD-8337A31F6093Q35595654-25320C54-116A-4904-939C-4EC7320570B6Q35596886-94A63310-604E-43A1-914B-B6ADDD9E6576Q35809437-EA05A574-C288-4C19-A2C2-4685076CAFAEQ36036768-3805A320-11FA-4E43-B852-E321895FBA7FQ36086012-25DE0867-4D8C-4600-82C7-FA2AD5F22FC5Q36204153-031005D0-879E-41AA-96C7-BB86F10707FDQ36376786-40825232-1977-4E04-B2EF-BD0B235137F3Q36407290-1D8921C6-B68D-4B0F-AA9C-E8D10D0F663EQ36419333-28F97AC6-279A-4003-A03E-BB7808564147Q36609410-11B5A4AC-00B0-46A9-8252-588AC2C03984
P2860
Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Postprandial plasma 5-hydroxyt ...... bowel syndrome: a pilot study
@ast
Postprandial plasma 5-hydroxyt ...... bowel syndrome: a pilot study
@en
Postprandial plasma 5-hydroxyt ...... bowel syndrome: a pilot study
@nl
type
label
Postprandial plasma 5-hydroxyt ...... bowel syndrome: a pilot study
@ast
Postprandial plasma 5-hydroxyt ...... bowel syndrome: a pilot study
@en
Postprandial plasma 5-hydroxyt ...... bowel syndrome: a pilot study
@nl
prefLabel
Postprandial plasma 5-hydroxyt ...... bowel syndrome: a pilot study
@ast
Postprandial plasma 5-hydroxyt ...... bowel syndrome: a pilot study
@en
Postprandial plasma 5-hydroxyt ...... bowel syndrome: a pilot study
@nl
P2093
P2860
P3181
P356
P1433
P1476
Postprandial plasma 5-hydroxyt ...... bowel syndrome: a pilot study
@en
P2093
C P Bearcroft
M J Farthing
P2860
P3181
P356
10.1136/GUT.42.1.42
P407
P577
1998-01-01T00:00:00Z